Shionogi & Co., Ltd. (OTCMKTS:SGIOF – Get Free Report) shares dropped 13.8% on Thursday . The company traded as low as $12.21 and last traded at $12.21. Approximately 300 shares traded hands during trading, a decline of 87% from the average daily volume of 2,323 shares. The stock had previously closed at $14.17.
Shionogi & Co., Ltd. Stock Performance
The stock has a 50 day moving average price of $13.19 and a two-hundred day moving average price of $29.57.
Shionogi & Co., Ltd. Company Profile
Shionogi & Co, Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Cabenuva and Apretude an anti-HIV and HIV prophylactic drug; Xocova an oral COVID-19 treatment drug; Finibax a carbapenem antibiotic; Xofluza, an influenza antiviral drug; and Tivicay, an anti-HIV drug.
Featured Stories
- Five stocks we like better than Shionogi & Co., Ltd.
- The Role Economic Reports Play in a Successful Investment Strategy
- Top 3 Investment Themes to Watch for in 2025
- Top Stocks Investing in 5G Technology
- Mega Buybacks in 2025: Why These 3 Leading Stocks Are Buys
- The Basics of Support and Resistance
- AMD vs. NVIDIA: The Better Semiconductor Bet for 2025
Receive News & Ratings for Shionogi & Co. Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shionogi & Co. Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.
